David West

Too many startups assume: 𝙩𝙝𝙚𝙧𝙚’𝙨 𝙖 𝘾𝙋𝙏 𝙘𝙤𝙙𝙚 → 𝙩𝙝𝙚𝙧𝙚𝙛𝙤𝙧𝙚 𝙩𝙝𝙚𝙧𝙚’𝙨 𝙖 𝙗𝙪𝙨𝙞𝙣𝙚𝙨𝙨. Reality is rarely that linear. Viability tends to unfold in fits and starts, shaped by payer coverage, provider workflows, and the real operational burden behind reliable billing. ⚙️📉 Inspired by Matt Kamen's excellent post on CPT adoption curves & the recent ACCESS discussion, we’re sharing our internal framework: 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐭𝐨 𝐀𝐬𝐤 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐞𝐭𝐭𝐢𝐧𝐠 𝐨𝐧 𝐚 𝐍𝐞𝐰 𝐁𝐢𝐥𝐥𝐢𝐧𝐠 𝐂𝐨𝐝𝐞 It goes deeper than payment policy — covering clinical and documentation requirements, enrollment and service mechanics, operational readiness, and the maturity of the CPT pathway. 🧠📋 If you’re evaluating a CPT-driven business model — or working with someone who is — comment “𝘾𝙋𝙏” below + DM me & I’ll share the document. 📄➡️ #startups #HealthcarePolicy #HealthTech #CMMI #ACCESSModel #Medicare #DigitalHealth

42

64 Comments

Clinicians want to use AI but don’t have the bandwidth to evaluate all the different models. Meet Health Olymp, an AI tool purpose-built for clinicians. Here’s why this matters 👇 1. Health and life science experts gain instant access to frontier models for free. No procurement hoops or IT bottlenecks. Every clinician gets their own sandbox to explore. 2. Clinicians can compare models side by side and pick the one that works best for their use case. That transparency builds trust and sparks ideas for novel AI applications in care delivery, diagnostics, and research. 3. Most AI benchmarks are too generic or disconnected from clinical reality. Health Olymp brings frontline feedback into the loop, helping the industry identify models that perform reliably in real world clinical environments. Congrats to Ruslan Nazarenko and the Lumos team as they put AI model benchmarking directly into the hands of healthcare professionals. ⬇️ (link in comments)

148

53 Comments

Excited to spotlight Anna Marie Wagner and our AI Biohub initiative! Anna Marie breaks down why AI-native biotech startups need specialized support—and how we’re building that ecosystem. Plus, catch her on The Dish podcast sharing insights on early AI adoption in biotech and leading multidisciplinary teams. C10 Labs

26

Sophont just released Medmarks v0.1: a new evaluation suite for assessing the medical capabilities of LLMs. This suite is the largest completely open-source automated evaluation suite for medical capabilities, with a total of 20 benchmarks. It covers tasks like answering patient questions to detecting errors in clinical notes. Here are the early results (full results at medmarks.ai). Interesting to filter them by model size, open-source, etc:

23

1 Comment

#AmTech Weekly Roundup:    Citizen Health raised $30 million in Series A funding from 8VC, Headline, and Transformation Capital. Citizen is building a healthcare advocacy and navigation platform for patients with chronic illnesses.  Farid Vij, Nasha Fitter Vulcan Elements raised $65 million in Series A funding from Altimeter and One Investment Management. Vulcan is reshoring production of rare-earth magnets, which are used in everything from drones to semiconductor fabrications to hard drives and automotive vehicles.   John Maslin, Piotr Kulik GoodShip raised $25 million in Series B funding from Greenfield Partners, Bessemer Venture Partners, and Ironspring Ventures. Goodship is building an AI-powered freight management platform, analyzing shipping and operations data to reduce transportation costs and lateness.   Ryan Soskin, David Tsai #SupplyChain #Healthcare #CriticalMinerals #VC

38

10 Comments

Benchmarking the Future of Medical AI Agents: Really interesting paper introducing the first benchmark to evaluate how large language models function as medical agents inside EHRs. Traditional LLMs (like ChatGPT) act as chatbots providing answers to prompts. But "agents can proactively interpret high-level instructions, plan actions, interact with external systems, and iteratively refine their responses." That shift could help reduce clinician burnout, improve clinical care quality, and close workforce gaps. MedAgentBench tests 300 clinically derived tasks across 100 patient profiles (700K+ data points) in a FHIR-compliant virtual EHR. State-of-the-art models showed promise but with wide variation. Claude 3.5 Sonnet v2 topped the field at a 69.7% success rate. Impressive, but still far from reliable for clinical use where errors in medical records can have serious consequences. However, if current trends hold (as METR notes, AI’s ability to complete long tasks is doubling roughly every 7 months), today’s ~70% performance could reach clinically sound thresholds much sooner than expected. Just as MedAgentBench creates a virtual EHR to test AI agents in medicine, education needs its own suite of agentic benchmarks. Imagine an assessment agent that continuously measures student progress, an SIS agent (like an educational EHR) that integrates student records, a science of reading agent that adapts instruction to phonics and fluency needs, an HQIM agent that generates and sequences high-quality instructional materials, and a coherence agent that reviews all of this to ensure alignment with learning standards and the evidence base. Benchmarks could test whether these agents work together reliably—retrieving data, planning instruction, scaffolding practice, and adjusting in real time. Without such benchmarks, we risk deploying systems that look impressive in demos but fail to deliver meaningful learning gains. https://lnkd.in/gnzCwbi7

10

1 Comment

Epic’s UGM is basically Apple’s WWDC for healthcare nerds, and this year’s big reveal was native AI scribing. Why it matters: scribing just became a feature, not a company. But startups still have room to win by filling Epic’s workflow gaps. Read below for some great insights from Avo’s CEO Yair Saperstein, MD MPH!

28

MedTech fundraising is tough, but it doesn’t have to be confusing. Too many startups focus on the science and leave fundraising strategy as an afterthought. The result? Costly mistakes, tough term sheets, and lost investor confidence. We put together this practical fundraising guide for MedTech founders covering: -Which funding options make sense early -How to navigate Angels vs. VCs -What every pitch deck must include -What investors really check in due diligence -How to plan your exit early The right strategy can mean the difference between a successful raise and months of frustration. Ready to get investor-ready? Book your FREE 30-min consultation with Adnan Ashfaq: https://simplimedica.com/ #MedTech #Fundraising #Startups #RegulatoryAffairs #MedicalDevices #HealthcareInnovation

2